| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2011 | US7985770 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 07/26/2011 | US7985769 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 07/26/2011 | US7985768 Compounds as cannabinoid receptor ligands |
| 07/26/2011 | US7985767 Therapeutic amides |
| 07/26/2011 | US7985766 anticholinergic glycopyrrolate or salt and long-acting beta 2 sympathomimetic agent selected from formoterol or salmeterol or salts; chronic obstructive pulmonary disease (COPD) and asthma; inhaled |
| 07/26/2011 | US7985765 Therapeutic substituted pyrroles |
| 07/26/2011 | US7985764 Amide derivative or salt thereof |
| 07/26/2011 | US7985763 Hepatitis C virus inhibitors |
| 07/26/2011 | US7985762 Inhibitors of serine proteases |
| 07/26/2011 | US7985761 Diphenylurea derivatives and their use as chloride channel blockers or BKCa channel modulators |
| 07/26/2011 | US7985760 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 07/26/2011 | US7985759 Dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 07/26/2011 | US7985758 Piperidine derivatives for treatment of Alzheimer's disease |
| 07/26/2011 | US7985757 Argatroban formulation |
| 07/26/2011 | US7985756 Modulation of neurogenesis by PDE inhibition |
| 07/26/2011 | US7985755 2,4-diaminoquinazolines for spinal muscular atrophy |
| 07/26/2011 | US7985754 Selective antagonists of A2A adenosine receptors |
| 07/26/2011 | US7985753 Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators |
| 07/26/2011 | US7985752 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof |
| 07/26/2011 | US7985751 Piperazine derivatives |
| 07/26/2011 | US7985750 Substituted oxazolidinone derivatives |
| 07/26/2011 | US7985749 Compounds and compositions as cathepsin S inhibitors |
| 07/26/2011 | US7985748 ALPHA2C adrenoreceptor agonists |
| 07/26/2011 | US7985747 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 07/26/2011 | US7985746 Imidazoazepinone compounds |
| 07/26/2011 | US7985745 Including inflammatory pain, post surgical pain, and neuropathic pain; administering a histamine H4 receptor ligand alone or in combination with a histamine H1, H2, or H3 receptor antagonist or an enzyme inhibitor |
| 07/26/2011 | US7985744 Vitamin D derivatives |
| 07/26/2011 | US7985743 Topical pain reliever and method of making the same |
| 07/26/2011 | US7985742 Bioremedial absorption composition for use in sanitary napkin, diapers and medical devices |
| 07/26/2011 | US7985741 therapy for bone disorders; antiarthritic agents; osteoarthritis; antiinflamamtory agents |
| 07/26/2011 | US7985740 Purine derivatives as agonists of the adenosine A2A receptor |
| 07/26/2011 | US7985739 Generating transgenic cells via insertional event generated by modified transposase; mobile genetic element for use as tool in heterologous gene transfer |
| 07/26/2011 | US7985738 Cytosine nucleoside analogs and isoflavones and uses thereof |
| 07/26/2011 | US7985737 Compositions and methods for the regulation of homocysteine levels within the body |
| 07/26/2011 | US7985727 Apo A-I mimetic peptides and methods of treatment |
| 07/26/2011 | US7985601 Drug delivery vehicle; tissue engineering |
| 07/26/2011 | US7985581 Multiple RNA polymerase III promoter expression constructs |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985435 Triterpene compositions and methods for use thereof |
| 07/26/2011 | US7985429 Flavored colonic cleansing system |
| 07/26/2011 | US7985422 A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release |
| 07/26/2011 | US7985421 Sustained release formulations of guaifenesin and additional drug ingredients |
| 07/26/2011 | US7985420 Sustained release of guaifenesin combination drugs |
| 07/26/2011 | US7985418 Aliphatic amine polymer salts for tableting |
| 07/26/2011 | US7985414 Allograft composite of a biodegradable polyurethane based on a polyisocyanate and an optionally hydroxylated biomolecule to form a matrix for embedded reinforcement of bone and/or bone substitutes; resorbable polymers having osteopromotive/osteopermissive properties; no undesirable immune response |
| 07/26/2011 | US7985406 For cellular delivery; heteropolymer containing amine containing monomer and hydrophobic monomers |
| 07/26/2011 | US7985405 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 07/26/2011 | CA2729522A1 Supplement composition and method of use |
| 07/26/2011 | CA2724295C Dibenzo (b,f) azepine intermediates |
| 07/26/2011 | CA2673461C 5.alpha.-androstane-3,6,17-trione (kneller's trione) and methods of use therefor |
| 07/26/2011 | CA2644467C Alpha crystalline form of perindopril arginine salt, its preparation process, and the pharmaceutical compositions that contain it |
| 07/26/2011 | CA2629402C Beta-secretase modulators and methods of use |
| 07/26/2011 | CA2624602C Process for preparing 6-substituted-7-azaindoles |
| 07/26/2011 | CA2621134C Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 07/26/2011 | CA2612740C Pyridazine derivatives |
| 07/26/2011 | CA2603185C Propane-1,3-dione derivative or salt thereof |
| 07/26/2011 | CA2571361C Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 07/26/2011 | CA2535401C Emulsive composition containing dapsone |
| 07/26/2011 | CA2530452C Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators |
| 07/26/2011 | CA2510514C Alpha-aminoamide derivatives useful as antimigraine agents |
| 07/26/2011 | CA2508611C Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 07/26/2011 | CA2508412C Pesticidal 5-(acylamino) pyrazole derivatives |
| 07/26/2011 | CA2505937C Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropaties induced by anticancer agents |
| 07/26/2011 | CA2502877C Metastable benzoxepine derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes forthe preparation thereof |
| 07/26/2011 | CA2502870C High-molecular weight derivatives of camptothecins |
| 07/26/2011 | CA2498785C Pyrrolidone derivatives as maob inhibitors |
| 07/26/2011 | CA2498285C Aroyl-piperidine derivatives |
| 07/26/2011 | CA2496308C Alkyl-substituted pyrazolopyrimidines |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 07/26/2011 | CA2481325C Anti-hiv composition, production method thereof and medicament |
| 07/26/2011 | CA2479632C Method for increasing the bone mineral density of a mammal using n-acylated glucosamines |
| 07/26/2011 | CA2469625C Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 07/26/2011 | CA2464777C Method of suppressing the germination of candida albicans using whey-derived free fatty acids |
| 07/26/2011 | CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands |
| 07/26/2011 | CA2463615C Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/26/2011 | CA2461941C Anti-irritating rosacea treatment |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2422974C Medicaments based on progestins for dermal use |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2367787C Ligands for metabotropic glutamate receptors |
| 07/26/2011 | CA2360452C C-21 modified epothilones |
| 07/26/2011 | CA2333162C Process for producing composite preparation containing nucleic acid |
| 07/26/2011 | CA2267743C Low dose estrogen interrupted hormone replacement therapy |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/26/2011 | CA2189418C Method of colonic evacuation |
| 07/22/2011 | CA2749843A1 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer |
| 07/21/2011 | WO2011088418A2 Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate |
| 07/21/2011 | WO2011088345A1 Inhibitors of flaviviridae viruses |
| 07/21/2011 | WO2011088303A1 Inhibitors of flaviviridae viruses |
| 07/21/2011 | WO2011088267A1 Methods and compositions for treating bleeding disorders |
| 07/21/2011 | WO2011088209A2 1-deoxy analogs of vitamin d-related compounds |
| 07/21/2011 | WO2011088208A1 Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol |
| 07/21/2011 | WO2011088201A1 Voltage-gated sodium channel blockers |
| 07/21/2011 | WO2011088192A1 Compounds and methods |
| 07/21/2011 | WO2011088188A1 Use of an adrenal hormone-modifying agent |